EGFR C797S mutation mediates resistance to third-generation inhibitors in T790M-positive non-small cell lung cancer
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1756-8722
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
EGFR C797S mutation mediates resistance to third-generation inhibitors in T790M-positive non-small cell lung cancer ; volume:9 ; number:1 ; day:22 ; month:7 ; year:2016 ; pages:1-5 ; date:12.2016
Journal of hematology & oncology ; 9, Heft 1 (22.7.2016), 1-5, 12.2016
- Urheber
-
Wang, Shuhang
- Beteiligte Personen und Organisationen
-
Tsui, Stella T.
Liu, Christina
Song, Yongping
Liu, Delong
SpringerLink (Online service)
- DOI
-
10.1186/s13045-016-0290-1
- URN
-
urn:nbn:de:1111-201607256269
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:01 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Wang, Shuhang
- Tsui, Stella T.
- Liu, Christina
- Song, Yongping
- Liu, Delong
- SpringerLink (Online service)
Ähnliche Objekte (12)
Third-generation inhibitors targeting EGFR T790M mutation in advanced non-small cell lung cancer
Emerging strategies to overcome resistance to third-generation EGFR inhibitors
Plasma metabolomics profiling of EGFR-mutant NSCLC patients treated with third-generation EGFR-TKI
Third-generation prospect theory
Third-generation prospect theory
Third-generation femtosecond technology
Second- and third-generation ALK inhibitors for non-small cell lung cancer
Fatty acid synthase mediates EGFR palmitoylation in EGFR mutated non‐small cell lung cancer
CXCR1+ neutrophil infiltration orchestrates response to third-generation EGFR-TKI in EGFR mutant non-small-cell lung cancer
An oligoclonal antibody durably overcomes resistance of lung cancer to third‐generation EGFR inhibitors
Trastuzumab emtansine delays and overcomes resistance to the third-generation EGFR-TKI osimertinib in NSCLC EGFR mutated cell lines
Third‐Generation Sequencing of Epigenetic DNA
Third-generation inhibitors targeting EGFR T790M mutation in advanced non-small cell lung cancer
Emerging strategies to overcome resistance to third-generation EGFR inhibitors
Plasma metabolomics profiling of EGFR-mutant NSCLC patients treated with third-generation EGFR-TKI
Third-generation prospect theory
Third-generation prospect theory
Third-generation femtosecond technology
Second- and third-generation ALK inhibitors for non-small cell lung cancer
Fatty acid synthase mediates EGFR palmitoylation in EGFR mutated non‐small cell lung cancer
CXCR1+ neutrophil infiltration orchestrates response to third-generation EGFR-TKI in EGFR mutant non-small-cell lung cancer
An oligoclonal antibody durably overcomes resistance of lung cancer to third‐generation EGFR inhibitors
Trastuzumab emtansine delays and overcomes resistance to the third-generation EGFR-TKI osimertinib in NSCLC EGFR mutated cell lines
Third‐Generation Sequencing of Epigenetic DNA
Third-generation inhibitors targeting EGFR T790M mutation in advanced non-small cell lung cancer
Emerging strategies to overcome resistance to third-generation EGFR inhibitors
Plasma metabolomics profiling of EGFR-mutant NSCLC patients treated with third-generation EGFR-TKI
Third-generation prospect theory
Third-generation prospect theory
Third-generation femtosecond technology
Second- and third-generation ALK inhibitors for non-small cell lung cancer
Fatty acid synthase mediates EGFR palmitoylation in EGFR mutated non‐small cell lung cancer
CXCR1+ neutrophil infiltration orchestrates response to third-generation EGFR-TKI in EGFR mutant non-small-cell lung cancer
An oligoclonal antibody durably overcomes resistance of lung cancer to third‐generation EGFR inhibitors
Trastuzumab emtansine delays and overcomes resistance to the third-generation EGFR-TKI osimertinib in NSCLC EGFR mutated cell lines